News - Tykerb

Filter

Current filters:

Tykerb

Popular Filters

Another blow for Pharma, as India revokes Tykerb patent

02-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) has confirmed that India's Intellectual Property Appellate…

Asia-PacificGlaxoSmithKlineLegalOncologyPatentsPharmaceuticalTykerb

GlaxoSmithKline's Tykerb/Tyverb and chemotherapy combo fails in gastric cancer

04-06-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) says that its study of Tykerb/Tyverb (lapatinib) in combination…

GlaxoSmithKlineOncologyPharmaceuticalResearchTykerbTyverb

BRIC countries' breast cancer market to see 8% annual growth to 2017

14-02-2013

The market for breast cancer therapies in the BRIC countries (Brazil, Russia, India and China) will grow…

GlaxoSmithKlineGlobalHerceptinMarkets & MarketingOncologyPharmaceuticalRocheTykerb

New Zealand to fund new cancer drugs Tykerb and Votrient

05-03-2012

The Pharmaceutical Management Agency of New Zealand, PHARMAC, says it is funding two new targeted cancer…

Asia-PacificGlaxoSmithKlineOncologyPharmaceuticalPricingRegulationTykerbVotrient

GlaxoSmithKline files for Tykerb/Tyverb with trastuzumab in USA and Europe

17-02-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) said yesterday that it has submitted regulatory applications…

EuropeGlaxoSmithKlineNorth AmericaOncologyPharmaceuticalRegulationtrastuzumabTykerbTyverb

News briefs from breast cancer meeting

12-12-2011

In further news from the the San Antonio Breast Cancer Symposium (SABCS) that took place in Texas, USA…

AlgetaAlpharadinBayerGlaxoSmithKlineOncologyPharmaceuticalResearchTykerb

Company Spotlight

Fibrotech

Fibrotech

Back to top